NSW Health logs 1,180 emergency visits tied to unapproved peptide injections
Retatrutide accounted for 71% of presentations, and monthly cases rose from five in July 2025 to 217 in September 2026.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 18 23:03 ETSource: The Nightly
The wire
- 01NSW Health figures covering July 2025 to September 2026 record 1,180 emergency department presentations after unapproved peptide injections, with abdominal pain, nausea, vomiting, chest pain and anaphylaxis among reactions.
- 02A quarter of patients were aged 16 to 24 and 51% were men, and the agency names BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as products that may be unlawful to import, supply or advertise in Australia.
- 03Chief Health Officer Kerry Chant warns label contents and strength vary between products, and the data do not confirm what the injected material actually contained.
From the source
Read at thenightly.com.au‘Alarming’: Warning as peptide use causes spike in ED visits
Fuelled by social media influencers chasing the elixir of youth, customers caught in the dangerous peptide craze are putting pressure on emergency departments.
